ArticleTherapeutic advances in medical oncology2026

TROPION-Lung14 study protocol: a phase III study of osimertinib in combination with datopotamab deruxtecan versus osimertinib alone as first-line treatment for patients with

Shun Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.